FDA Announces 2013 Generic Drug Active Pharmaceutical Ingredient and Finished Dosage Form Facility User Fee Rates (JSON)

lexblog.com/lib/RVNE4GYQview recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Announces 2013 Generic Drug Active Pharmaceutical Ingredient and Finished Dosage Form Facility User Fee Rates",
    "url": "https://www.lexblog.com/2013/01/29/fda-announces-2013-generic-drug-active-pharmaceutical-ingredient-and-finished-dosage-form-facility-user-fee-rates/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-RVNE4GYQ",
        "url": "https://www.lexblog.com/lib/RVNE4GYQ/"
    },
    "datePublished": "2013-01-29T11:58:16-05:00",
    "dateModified": "2022-07-22T19:02:56-04:00",
    "author": {
        "@type": "Person",
        "name": "Jennifer Pike"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Reed Smith LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Health Industry Washington Watch",
    "about": "Other",
    "sourceUrl": "http://localhost/healthwatch/2013/01/29/fda-announces-2013-generic-drug-active-pharmaceutical-ingredient-and-finished-dosage-form-facility-user-fee-rates/",
    "sourceStability": "may-move"
}